ArticlePurinergic signalling2017
A covalent antagonist for the human adenosine A
Article in Purinergic signalling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 30 citations in OpenAlex.
- Ligand-directed covalent labelling of adenosine receptors.Purinergic signalling · 2025Article
- Advances in sulfonyl exchange chemical biology: expanding druggable target space.Chemical science · 2025Review
- Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as AJournal of medicinal chemistry · 2024Article
- Development of subtype-selective covalent ligands for the adenosine ARSC medicinal chemistry · 2022Article
- Irreversible Antagonists for the Adenosine AMolecules (Basel, Switzerland) · 2022Article
- Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.Molecular diversity · 2022Review
- International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.Pharmacological reviews · 2022Review
- Identification of V6.51L as a selectivity hotspot in stereoselective AScientific reports · 2021Article
- Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2.Journal of medicinal chemistry · 2021Article
- Molecular probes for the human adenosine receptors.Purinergic signalling · 2021Review
- Covalent Inhibition of the Histamine HMolecules (Basel, Switzerland) · 2019Article
- Chemical Probes for the Adenosine Receptors.Pharmaceuticals (Basel, Switzerland) · 2019Review
- Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine AJournal of medicinal chemistry · 2019Article
- Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization.Journal of medicinal chemistry · 2019Article
- Article
- An Affinity-Based Probe for the Human Adenosine AJournal of medicinal chemistry · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The structure of the human A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.